SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-24-041187
Filing Date
2024-03-29
Accepted
2024-03-29 16:58:11
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-1/A tm248533d2_s1a.htm S-1/A 412814
2 EXHIBIT 5.1 tm248533d2_ex5-1.htm EX-5.1 11466
3 EXHIBIT 23.1 tm248533d2_ex23-1.htm EX-23.1 2351
4 GRAPHIC tm248533d1_s1sp1img001.jpg GRAPHIC 11805
5 GRAPHIC tm248533d1_s1img01.jpg GRAPHIC 9014
6 GRAPHIC tm248533d2_ex5-1img001.jpg GRAPHIC 2277
7 GRAPHIC tm248533d2_ex5-1img002.jpg GRAPHIC 1532
  Complete submission text file 0001104659-24-041187.txt   462303
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-278028 | Film No.: 24804647
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)